2m 2m 2m 2m 2m 2m 2m
Curanex Pharma (CURX)
NASDAQ
$5.06+$0.35 (+7.43%)
Price as of Aug 21, 2026 7:30 PM EDT- $133.6MMarket Cap
- N/A1-Year Change
- BiotechnologyIndustry
Curanex Pharma (CURX)
$5.06+$0.35 (+7.43%)
CURX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $4.71 | ||
Change | -$0.56 (-10.63%) | ||
Open | $5.10 | ||
High | $5.38 | ||
Low | $4.70 | ||
Previous Close | $5.27 | ||
Volume | 28,570 | ||
30-Day Average Volume | 15,961 | ||
1-Week Change | 8.33% | ||
1-Month Change | 16.47% | ||
1-Year Change | N/A | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 28.4M | ||
Total Assets | $5.1M | ||
Market Cap | $133.6M | ||
Enterprise Value | $130.7M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | N/A | ||
Free Cash Flow | -$1.1M | ||
EBIT | $0.00 | ||
EBITDA | $0.00 | ||
Net Working Capital | $4.7M | ||
EPS | -$2.40 | ||
Enterprise Value/EBITDA | N/A | ||
Enterprise Value/Revenue | N/A | ||
P/B | N/A | ||
P/E | -2 | ||
PEG | 0 | ||
Price/Free Cash Flow | -124 | ||
Price/Operating Cash Flow | -124 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 20 | ||
Last Split Date | 08/20/2026 | ||
Earnings & Revenue